on Xlife Sciences AG (isin : CH0461929603)
Xlife Sciences AG Enters Strategic Collaboration in Asia
Xlife Sciences AG, a Swiss-based life sciences incubator, announced a Memorandum of Understanding with Huraypositive Corp. and OncoMASTER Inc. to explore digital health and precision oncology in Asia. This alliance aims to leverage the strengths of each company for clinical innovation and global reach.
The collaboration focuses on expanding into Asia using Huraypositive's healthcare ecosystem and OncoMASTER's AI expertise. It also seeks to innovate healthcare platforms by integrating AI, digital health, and clinical insights to advance personalized care. Additionally, this partnership will explore commercialization opportunities in Europe using Xlife Sciences’ network.
This agreement signifies a key step towards international expansion and bridging academic research with clinical applications, reflecting the companies' shared vision for transforming healthcare solutions.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Xlife Sciences AG news